BioSpace News Archive

Mallinckrodt plc, a global biopharmaceutical company, announced that it will report first quarter 2020 earnings results for the period ended March 27, 2020 on Tuesday, May 5, 2020.

Non-branded versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® are now available for order by U.S. pharmacies – adding to the broad suite of affordability options offered by Eli Lilly and Company.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, announces that the U.S. Food and Drug Administration has accepted the Investigational New Drug application for AUTO1, its lead CAR T product candidate for the treatment of adults with acute lymphoblastic leukemia.

Coalition created a publicly available centralized repository to enhance research

Novartis Pharmaceuticals Canada Inc. is pleased to announce that KISQALI® is now indicated when used in combination for the treatment of women with hormone receptor -positive, human epidermal growth factor receptor 2 -negative advanced or metastatic breast cancer regardless of their menopause status and in combination with various approved hormonal treatment options.

Bio-Techne Corporation announced the upcoming release of RePlex™ for use on the Jess instrument, a member of the Simple Western™ instrument family.

Zimmer Biomet Holdings, Inc. announced a change in the location of its 2020 Annual Meeting of Shareholders.

Centene announced a series of initiatives designed to support the disability community affected by the COVID-19 pandemic.